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I read with interest the viewpoint by Guidet and colleagues 
addressing controversies regarding colloid solution carrier 
ﬂ  uids [1]. Instead of oﬀ  ering a balanced view, however, the 
article focused on the refutation of dilutional hyper-
chloraemic acidosis, depicting it as a clinically innocent 
inevitability we should accept rather than try to avoid.
Th  e authors initially forward the view that ‘unless 
recommendations are based on high quality primary 
research … clinicians would be better oﬀ   making clinical 
decisions on the basis of primary data’ – just to end doing 
the opposite by recommending against the use of 
balanced colloid solutions based on ‘limited published 
information’ [1]. To the best of my knowledge there are 
no published data suggesting adverse eﬀ  ects of balanced 
solutions compared with isotonic saline, yet there 
remains the (non?)issue of hyperchloraemic acidosis. 
Sound judge  ment suggests that if a clinical uncertainty 
can be avoided without suggestion of doing harm, then a 
clinician may expect to be allowed the freedom of making 
such a choice.
Th  e conclusion this review should have is the one it 
begins with – the informed clinician should be left to 
make the decision in which patients to use a balanced 
colloid and in which to use an isotonic saline-based 
solution, until evidence for clear beneﬁ  t or harm can be 
demonstrated, as recently suggested by one of the authors 
herself [2].
Since no data suggestive of balanced colloid being 
inferior to saline-based solutions are presented, it seems 
unusual to forward opinions dismissive of existing non-
inferiority evidence since non-inferiority trials have 
become the mainstay for introducing new drugs [3].
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We believe we provided strong evidence demonstrating 
that dilutional-hyperchloraemic acidosis is observed only 
with a large volume of isotonic saline, is transient and is 
not associated with adverse eﬀ  ects.
As a matter of fact, if colloid is used as part of ﬂ  uid 
resuscitation, the total infused volume is much smaller 
compared with a crystalloid-only strategy. As a conse-
quence, the chloride and sodium load is reduced. More-
over, the use of balanced crystalloid together with an 
artiﬁ  cial colloid is able to reduce the additional beneﬁ  t of 
using a balanced colloid. Th  e beneﬁ   t of a balanced 
solution in terms of pH is reduced in cases of pre-existing 
acidosis with low serum bicarbonate [4].
Among the 10 articles dealing with balanced colloid 
solutions, eight were from the same author and the only 
study documenting superiority of balanced hydroxyethyl 
starch over albumin has been retracted [5]. Other articles 
are testing the eﬀ  ect of American balanced starches (that 
is, Hextend®; Biotime Inc., Berkeley, CA, USA) with a 
very high molecular weight and substitution ratio. 
Because of adverse eﬀ   ects on coagulation and renal 
function, these hydroxyethyl starches are not prescribed 
in Europe.
In balanced solution, the partial substitution of chloride 
by acetate might have a potential harmful eﬀ  ect with 
nitric oxide release, reduction of cardiac output and 
hypotension. One must remember that acetate has been 
banned by nephrologists in haemodialysis.
We do not advocate the use of balanced colloids, but 
balanced crystalloids may be of value for physicians using 
large volumes of crystalloids as the only resuscitation ﬂ  uid.
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